Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Iezza A"'
Autor:
Flavia Bigi, Enrica Manzato, Simona Barbato, Marco Talarico, Michele Puppi, Simone Masci, Ilaria Sacchetti, Roberta Restuccia, Miriam Iezza, Ilaria Rizzello, Chiara Sartor, Katia Mancuso, Lucia Pantani, Paola Tacchetti, Michele Cavo, Elena Zamagni
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 944 (2024)
This systematic review examines the available clinical data on CD34+ cell mobilization, collection, and engraftment in multiple myeloma patients treated with the anti-CD38 monoclonal antibodies daratumumab and isatuximab in clinical trials and in rea
Externí odkaz:
https://doaj.org/article/ca8c80232cb64f9c9adf1c517eb96ad0
Autor:
Elisa Tassinari, Nicole Conci, Giacomo Battisti, Francesco Porta, Valerio Di Scioscio, Maria Giulia Pirini, Dario de Biase, Maria Concetta Nigro, Miriam Iezza, Fausto Castagnetti, Luigi Lovato, Stefano Fanti, Maria Abbondanza Pantaleo, Margherita Nannini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPositron emission tomography (PET) with 18-fluorodeoxyglucose (18FDG) has proven to be highly sensitive in the early assessment of tumor response in gastrointestinal stromal tumors (GIST), especially in cases where there is doubt or when th
Externí odkaz:
https://doaj.org/article/4831301aeb1641c89d8c04247180d36d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Iurlo, D. Cattaneo, D. Consonni, F. Castagnetti, M. C. Miggiano, G. Binotto, M. Bonifacio, G. Rege-Cambrin, M. Tiribelli, F. Lunghi, A. Gozzini, P. Pregno, E. Abruzzese, I. Capodanno, C. Bucelli, M. Pizzuti, S. Artuso, M. Iezza, E. Scalzulli, G. La Barba, A. Maggi, S. Russo, C. Elena, A. R. Scortechini, A. Tafuri, R. Latagliata, G. Caocci, M. Bocchia, S. Galimberti, L. Luciano, C. Fava, R. Foà, G. Saglio, G. Rosti, M. Breccia
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
TKIs long-term treatment in CML may lead to persistent adverse events (AEs) that can promote relevant morbidity and mortality. Consequently, TKIs dose reduction is often used to prevent AEs. However, data on its impact on successful treatment-free re
Externí odkaz:
https://doaj.org/article/b301c0dcb99740a68845aace603611d1
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights.
Autor:
Iezza, Miriam1 (AUTHOR) miriam.iezza@studio.unibo.it, Cortesi, Sofia1 (AUTHOR) cecilia.monaldi2@unibo.it, Ottaviani, Emanuela2 (AUTHOR) emanuela.ottaviani@aosp.bo.it, Mancini, Manuela2 (AUTHOR) mancini_manu@yahoo.com, Venturi, Claudia2 (AUTHOR) claudia.venturi2@studio.unibo.it, Monaldi, Cecilia1 (AUTHOR) sara.desantis9@unibo.it, De Santis, Sara1 (AUTHOR) nicoletta.testoni@unibo.it, Testoni, Nicoletta1,2 (AUTHOR) simona.soverini@unibo.it, Soverini, Simona1 (AUTHOR) michele.cavo@unibo.it, Rosti, Gianantonio3 (AUTHOR) gianantonio.rosti@unibo.it, Cavo, Michele1,2 (AUTHOR) fausto.castagnetti@unibo.it, Castagnetti, Fausto1,2 (AUTHOR)
Publikováno v:
Cells (2073-4409). Jul2023, Vol. 12 Issue 13, p1703. 25p.
Autor:
Miriam Iezza, Sofia Cortesi, Emanuela Ottaviani, Manuela Mancini, Claudia Venturi, Cecilia Monaldi, Sara De Santis, Nicoletta Testoni, Simona Soverini, Gianantonio Rosti, Michele Cavo, Fausto Castagnetti
Publikováno v:
Cells, Vol 12, Iss 13, p 1703 (2023)
The introduction of tyrosine kinase inhibitors (TKIs) has changed the treatment paradigm of chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML patients, who now have a nearly normal life expectancy and, in some se
Externí odkaz:
https://doaj.org/article/664fdd7e85ad4784a4379cfac3a95011
Autor:
Alessandra Iurlo, Daniele Cattaneo, Silvia Artuso, Dario Consonni, Elisabetta Abruzzese, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Fausto Castagnetti, Sara Galimberti, Antonella Gozzini, Miriam Iezza, Roberto Latagliata, Luigiana Luciano, Alessandro Maggi, Maria Cristina Miggiano, Patrizia Pregno, Giovanna Rege-Cambrin, Sabina Russo, Anna Rita Scortechini, Agostino Tafuri, Mario Tiribelli, Carmen Fava, Gianantonio Rosti, Robin Foa, Massimo Breccia, Giuseppe Saglio
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Treatment-free remission (TFR) has become a primary therapeutic goal in CML and is also considered feasible by international guidelines. TKIs dose reduction is often used in real-life practice to reduce adverse events, although its impact on TFR is s
Externí odkaz:
https://doaj.org/article/65c0695e402745059fa9fbd7d9d31204
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
F. Castagnetti, M. Bocchia, E. Abruzzese, I. Capodanno, M. Bonifacio, G. Rege Cambrin, M. Crugnola, G. Binotto, C. Elena, A. Lucchesi, M. Bergamaschi, F. Albano, L. Luciano, F. Sorà, F. Lunghi, F. Stagno, M. Cerrano, A. Iurlo, A. R. Scortechini, S. Leonetti Crescenzi, R. Spadano, E. Trabacchi, M. Lunghi, G. Spinosa, D. Ferrero, D. Rapezzi, M. Ladetto, L. Nocilli, G. Gugliotta, M. Iezza, M. Cavo, G. Saglio, F. Pane, G. Rosti
Publikováno v:
HemaSphere, Vol 6, Pp 593-594 (2022)
Externí odkaz:
https://doaj.org/article/eda8e283ec6e4478a6fe0b8dc7a62503